• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Organisation › Details

M Ventures (Merck Ventures B.V., MV)

M Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact the company’s core business areas. From its headquarters in Amsterdam and offices in the US and Israel, M Ventures invests globally in transformational ideas driven by great entrepreneurs. M Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. M Ventures has a significant focus on early stage investing and company creation including the creation of spin-offs to leverage the company’s science and technology base. *

 

	Start	2016-06-08 renamed
	Group	Merck (DE) (Group)
	Predecessor	MS Ventures (Merck Serono Ventures)
	Industry	venture capital
	Industry 2	BIOTECH
	Person	Liechtenstein, Therese Maria (Merck (DE) 202004 at M Ventures)
	Person 2	Autret, Arnaud (Merck (DE) 202002 Investment Principal at M Ventures)
	Region	Amsterdam
	Country	Netherlands
	Street	84a Gustav Mahlerplein Ito Toren, 13th floor
	City	1082 MA Amsterdam
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	300,000,000 (capital, committed 2016-06-08)
		* Document for �About Section�: Anavo Therapeutics B.V.. (4/22/21). "Press Release: Anavo Therapeutics Launches with EUR 20 Million Seed Financing to Create Industry-Leading Pipeline of Allosteric Phosphatase Modulators". Leiden.
		Record changed: 2021-08-18

Advertisement

More documents for Merck (DE) (Group)

• [1] Merck KGaA. (8/23/21). "Press Release: Merck Statement on Phase II Study of Bintrafusp Alfa in First-Line Treatment of Biliary Tract Cancer". Darmstadt....
• [2] Merck KGaA. (7/23/21). "Press Release: Merck Announces Appointment of Head of China & International for Healthcare. Hong Chow Will Join the Healthcare Business Sector as Head of China & International on October 1". Darmstadt....
• [3] NanoSyrinx Ltd.. (7/19/21). "Press Release: NanoSyrinx Raises £6.2m to Develop Its Synthetic Biology Platform for Targeted Intracellular Engineering". Coventry....
• [4] Theolytics Ltd.. (7/8/21). "Press Release: Theolytics Expands Series A Financing and Welcomes M Ventures as a New Investor". Oxford....
• [5] Merck KGaA. (7/8/21). "Press Release: Merck and Inbrain Neuroelectronics Collaborate to Develop the Next Generation of Bioelectronic Therapies". Darmstadt....
• [6] MoonLake Immunotherapeutics AG. (7/1/21). "Press Release: MoonLake Immunotherapeutics Appoints Jorge Santos da Silva as CEO and Matthias Bodenstedt as CFO". Zug....
• [7] Merck KGaA. (6/29/21). "Press Release: Merck and B. Braun Join Forces in the Development of Bioelectronic Devices". Darmstadt....
• [8] Nucleai MD. (6/24/21). "Press Release: Nucleai and Merck KGaA Darmstadt, Germany Launch Translational Medicine Collaboration Utilizing Nucleai’s AI-Powered Biomarker Platform". Chicago, IL....
• [9] Indivumed GmbH. (6/2/21). "Press Release: Indivumed Launches the nRavel AI Platform for Cancer Research and Drug Development". Hamburg....
• [10] Merck KGaA. (5/27/21). "Press Release: Merck Collaborates with TU Darmstadt and Tufts University on Bioreactor Designs to Enable Cultured Meat Production". Darmstadt....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.